Nicholas Theodosakis Selected Research

BRD 7389

10/2017

p90RSK Blockade Inhibits Dual BRAF and MEK Inhibitor-Resistant Melanoma by Targeting Protein Synthesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicholas Theodosakis Research Topics

Disease

10	Neoplasms (Cancer) 01/2021 - 04/2009
10	Melanoma (Melanoma, Malignant) 01/2019 - 12/2014
2	COVID-19 01/2022 - 01/2021
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2009
2	Adenocarcinoma of Lung 11/2015 - 01/2009
2	Adenocarcinoma 05/2010 - 01/2009
2	Esophageal Neoplasms (Esophageal Cancer) 05/2010 - 04/2009
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Vitamin D Deficiency 01/2021
1	Opioid-Related Disorders (Opiate Addiction) 01/2021
1	Pain (Aches) 01/2021
1	Cutaneous Malignant Melanoma 01/2017
1	Pigmented Nevus (Melanocytic Nevus) 01/2015
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2009

Drug/Important Bio-Agent (IBA)

3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019 - 11/2015
3	Biomarkers (Surrogate Marker)IBA 10/2017 - 05/2016
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2021
2	Opioid Analgesics (Opioids)IBA 01/2021 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 10/2017 - 05/2010
2	Mechanistic Target of Rapamycin Complex 2IBA 03/2016 - 01/2015
2	Tumor Biomarkers (Tumor Markers)IBA 04/2009 - 01/2009
1	SteroidsIBA 01/2022
1	LigandsIBA 01/2022
1	Rituximab (Mabthera)FDA Link 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	EndorphinsIBA 01/2021
1	Vitamin D FDA LinkGeneric 01/2021
1	MelanocortinsIBA 01/2021
1	Terpenes (Terpenoids)IBA 01/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019
1	BI D1870IBA 10/2017
1	VemurafenibIBA 10/2017
1	BRD 7389IBA 10/2017
1	AZD 6244IBA 10/2017
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 10/2017
1	Mitogen-Activated Protein KinasesIBA 10/2017
1	5-hydroxymethylcytosineIBA 01/2017
1	5-Methylcytosine (5 Methylcytosine)IBA 01/2017
1	Methionine (L-Methionine)FDA Link 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 03/2016
1	MethyltransferasesIBA 03/2016
1	Topoisomerase InhibitorsIBA 11/2015
1	Docetaxel (Taxotere)FDA Link 11/2015
1	Taxoids (Taxanes)IBA 11/2015
1	Apoptosis Regulatory ProteinsIBA 11/2015
1	Monoclonal AntibodiesIBA 11/2015
1	Proto-Oncogene Proteins B-rafIBA 07/2015
1	Glucose (Dextrose)FDA LinkGeneric 07/2015
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2010
1	Bortezomib (Velcade)FDA Link 05/2010
1	Vorinostat FDA Link 05/2010
1	Histone Deacetylases (Histone Deacetylase)IBA 05/2010
1	Cadherins (E-Cadherin)IBA 05/2010
1	CytokinesIBA 05/2010
1	Transforming Growth Factor beta (TGF-beta)IBA 05/2010
1	Therapeutic UsesIBA 05/2010
1	Proteasome Endopeptidase Complex (Proteasome)IBA 05/2010
1	Histone Deacetylase InhibitorsIBA 05/2010
1	Proteasome InhibitorsIBA 05/2010
1	ErbB Receptors (EGF Receptor)IBA 04/2009
1	Deoxyglucose (2 Deoxy D glucose)IBA 04/2009
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2009
1	Cyclin D1IBA 04/2009
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2009

Therapy/Procedure

7	Therapeutics 01/2022 - 04/2009
2	Drug Therapy (Chemotherapy) 01/2022 - 11/2015